45 Horsehill Road, Suite 106, Cedar Knolls, NJ 07927
(973) 509-0444
Follow us

HomeUniversity of California at Berkeley Clinical Study

Are you over the age of 50 and concerned about muscle loss?  Muscle loss impacts more than just how you look.  Muscle plays a vital role in balance, glucose metabolism and maintaining healthy bones.  Learn more about Yolked® with Fortetropin®, protein’s perfect partner at https://www.myoslongevity.com/.

University of California at Berkeley Clinical Study

Healthy AgingA randomized, double blind, placebo-controlled human clinical study was performed at the University of California, Berkeley and the University of Arkansas for Medical Sciences to evaluate the impact of Fortetropin supplementation on the rate of muscle protein synthesis in 20 healthy, older men and women (66.4 ± 4.5 yr) using a 2H2O labeling methodology and mass spectrometry analysis of muscle microbiopsy samples.  Subjects were given either Fortetropin or macronutrient matched placebo for 21 days prior to undergoing a muscle microbiopsy.  The key findings of this study were:

  • The average fractional synthesis for a majority of muscle proteins was higher in the Fortetropin group compared to placebo group (p<0.0001).
  • The overall magnitude of increase was 15% in the Fortetropin group, demonstrating a stimulatory effect on the rate of muscle protein synthesis.

Reference:

Evans, William, et al. “Effects of Fortetropin® on the rate of muscle protein synthesis in older men and women: a randomized, double-blinded, placebo-controlled study.” The Journals of Gerontology: Series A (2020).

MYOS CORP is an emerging company focused on improving muscle health through the development of advanced nutrition products.

Contact Us

CORPORATE HEADQUARTERS

Morris Technical Center
45 Horsehill Road, Suite 106
Cedar Knolls, NJ 07927
(973) 509-0444
info@myoscorp.com

SOCIAL & NEWSLETTER

Sign up for
our newsletter

Invalid or empty email
You have successfully subscribed to the newsletter.
Something went wrong. Your subscription failed.

Follow us